# Fios Genomics

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/fios-genomics

- Industry: Biotechnology
- Headquarters: Edinburgh, UK
- Website: www.fiosgenomics.com
- Total disclosed funding: $2.1M
- Latest round: Series D (Dec 7, 2015)
- Investors on record: 4

## About

Fios Genomics provides advanced bioinformatics analysis solutions to pharmaceutical, biotechnology, and academic organizations, facilitating drug discovery and development through data-driven insights.Fios Genomics specializes in bioinformatics services that enhance research and development in the life sciences sector. Founded in Edinburgh, UK, the company has undergone a Series D funding round in December 2015 that raised GBP 0.55 mn from Archangel Ventures and Scottish Enterprise, bringing the total amount raised to GBP 0.55 mn. The company's current valuation is GBP 2.76 mn.Fios Genomics offers comprehensive bioinformatics analysis solutions that facilitate research and development processes for various organizations. Their core services include gene expression analysis, single-cell analysis, genetic variation studies, proteomics, metabolomics data analysis, and clinical data applications. By leveraging advanced computational techniques, they provide actionable insights aimed at accelerating drug discovery for clients across North America, Europe, and parts of Asia.Fios Genomics operates on a B2B revenue model, primarily establishing partnerships and service agreements with pharmaceutical companies, contract research organizations (CROs), and academic institutions. Their transactions are typically tailored around specific project scopes, with costs structured based on the complexity and scale of services. Although specific pricing plans are not disclosed, flagship offerings like the Target Triage service are positioned to optimize the drug target selection process for their clients.Following the Series D funding round in December 2015, Fios Genomics plans to utilize the raised capital for product development and market expansion. While specific new products have not been detailed, the company aims to enhance their bioinformatics services to meet evolving client needs. Additionally, Fios Genomics is targeting expansion into new regions, particularly increasing their presence in Asia, by 2025.

## Funding rounds

- Series D, Dec 7, 2015, $0.8M — Archangel Ventures, Scottish Enterprise
- Series C, May 23, 2014, $0.5M — Scottish Enterprise, TRICAPITAL
- Series B, Jun 3, 2011, $0.8M — Archangels Investors Limited, Scottish Enterprise, TRICAPITAL

## Investors

- Archangels Investors Limited — Series B
- Scottish Enterprise (https://capitalatlas.ai/funds/scottish-enterprise) — Series B, Series C, Series D
- TRICAPITAL (https://capitalatlas.ai/funds/tricapital) — Series B, Series C
- Archangel Ventures (https://capitalatlas.ai/funds/archangel-ventures) — Series D